Skip to main content
SpringerLink
Log in

Alport Syndrome and Other Collagen Disorders

  • Living reference work entry
  • First Online:
Glomerulonephritis

  • 460 Accesses

Abstract

Type IV collagen is a ubiquitous component of basement membranes along with laminin, entactin/nidogen, and heparan sulfate proteoglycans. Six type IV collagen genes (COL4A1–COL4A6) encode six unique alpha chains of type IV collagen [α1(IV)–α6(IV)]. Mutations in several of the type IV collagen genes can cause a number of progressive and nonprogressive glomerular disorders. Mutations in COL4A3, COL4A4, and COL4A5 may cause Alport syndrome (AS), an inherited kidney disease that classically leads to ESKD, sensorineural hearing loss, and eye abnormalities in affected individuals. Mutations in COL4A6 along with COL4A5 are associated with AS accompanied by leiomyomatosis. Heterozygous mutations in COL4A3 and COL4A4 are associated with thin basement membrane nephropathy (TBMN), a generally nonprogressive kidney disorder presenting with isolated microscopic hematuria. Finally, mutations in COL4A1 cause hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC) syndrome. This chapter will review the genetics, clinical manifestations, pathology, diagnosis, and treatment of each of these type IV collagen disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  • Alessi M, Fabris A, Zambon A, Cremasco D, Muraro E, Dosa L, Anglani F, Del Prete D (2014) Pregnancy in Alport syndrome: a report of two differently-evolving cases. J Obstet Gynaecol: J Inst Obstet Gynaecol 34(1):98–100. doi:10.3109/01443615.2013.834299

    Article  CAS  Google Scholar 

  • Alport AC (1927) Hereditary familial congenital haemorrhagic nephritis. Br Med J 1:504–506

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Antignac C, Heidet L (1996) Mutations in Alport syndrome associated with diffuse esophageal leiomyomatosis. Contrib Nephrol 117:172–182

    Article  CAS  PubMed  Google Scholar 

  • Auwardt R, Savige J, Wilson D (1999) A comparison of the clinical and laboratory features of thin basement membrane disease (TBMD) and IgA glomerulonephritis (IgA GN). Clin Nephrol 52(1):1–4

    CAS  PubMed  Google Scholar 

  • Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL (1990) Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224–1227

    Article  CAS  PubMed  Google Scholar 

  • Bateman JF, Boot-Handford RP, Lamande SR (2009) Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations. Nat Rev Genet 10(3):173–183. doi:10.1038/nrg2520

    Article  CAS  PubMed  Google Scholar 

  • Blumenthal SS, Fritsche C, Lemann J (1988) Establishing the diagnosis of benign familial hematuria: the importance of examining the urine sediment of family members. JAMA 259:2263–2266

    Article  CAS  PubMed  Google Scholar 

  • Bostrom MA, Freedman BI (2010) The spectrum of MYH9-associated nephropathy. Clin J Am Soc Nephrol 5(6):1107–1113. doi:10.2215/CJN.08721209

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brainwood D, Kashtan C, Gubler MC, Turner AN (1998) Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int 53:762–766

    Article  CAS  PubMed  Google Scholar 

  • Burke JP, Clearkin LG, Talbot JF (1991) Recurrent corneal epithelial erosions in Alport’s syndrome. Acta Ophthalmol 69:555–557

    Article  CAS  Google Scholar 

  • Charbit M, Gubler MC, Dechaux M, Gagnadoux MF, Grunfeld JP, Niaudet P (2007) Cyclosporin therapy in patients with Alport syndrome. Pediatr Nephrol 22(1):57–63. doi:10.1007/s00467-006-0227-y

    Article  PubMed  Google Scholar 

  • Chen D, Jefferson B, Harvey SJ, Zheng K, Gartley CJ, Jacobs RM, Thorner PS (2003a) Cyclosporine a slows the progressive renal disease of alport syndrome (X-linked hereditary nephritis): results from a canine model. J Am Soc Nephrol 14(3):690–698

    Article  CAS  PubMed  Google Scholar 

  • Chen L, Miyamura N, Ninomiya Y, Handa JT (2003b) Distribution of the collagen IV isoforms in human Bruch’s membrane. Br J Ophthalmol 87(2):212–215

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen Z, Migeon T, Verpont MC, Zaidan M, Sado Y, Kerjaschki D, Ronco P, Plaisier E (2016) HANAC syndrome Col4a1 mutation causes neonate glomerular Hyperpermeability and adult glomerulocystic kidney disease. J Am Soc Nephrol 27(4):1042–1054. doi:10.1681/ASN.2014121217

    Article  CAS  PubMed  Google Scholar 

  • Cheong HI, Kashtan CE, Kim Y, Kleppel MM, Michael AF (1994) Immunohistologic studies of type IV collagen in anterior lens capsules of patients with Alport syndrome. Lab Investig 70:553–557

    CAS  PubMed  Google Scholar 

  • Cohen EP, Lemann J (1996) In hereditary nephritis angiotensin-converting enzyme inhibition decreases proteinuria and may slow the rate of progression. Am J Kid Dis 27:199–203

    Article  CAS  PubMed  Google Scholar 

  • Cosgrove D, Samuelson G, Meehan DT, Miller C, McGee J, Walsh EJ, Siegel M (1998) Ultrastructural, physiological, and molecular defects in the inner ear of a gene-knockout mouse model of autosomal Alport syndrome. Hear Res 121:84–98

    Article  CAS  PubMed  Google Scholar 

  • Crockett DK, Pont-Kingdon G, Gedge F, Sumner K, Seamons R, Lyon E (2010) The Alport syndrome COL4A5 variant database. Hum Mutat 31(8):E1652–E1657. doi:10.1002/humu.21312

    Article  PubMed  Google Scholar 

  • Dehan P, Van Den Heuvel LPWJ, Smeets HJM, Tryggvason K, Foidart J-M (1996) Identification of post-transplant anti-a5(IV) collagen alloantibodies in X-linked Alport syndrome. Nephrol Dial Transplant 11:1983–1988

    Article  CAS  PubMed  Google Scholar 

  • Deltas C, Pierides A (2015) COL4A3/COL4A4 heterozygous mutations with TBMN presenting as focal segmental glomerulosclerosis. Kidney Int 87(4):859. doi:10.1038/ki.2015.38

    Article  CAS  PubMed  Google Scholar 

  • Dische FE (1992) Measurement of glomerular basement membrane thickness and its application to the diagnosis of thin-membrane nephropathy. Arch Pathol Lab Med 116:43–49

    CAS  PubMed  Google Scholar 

  • Fallerini C, Dosa L, Tita R, Del Prete D, Feriozzi S, Gai G, Clementi M, La Manna A, Miglietti N, Mancini R, Mandrile G, Ghiggeri G, Piaggio G, Brancati F, Diano L, Frate E, Pinciaroli A, Giani M, Castorina P, Bresin E, Giachino D, De Marchi M, Mari F, Bruttini M, Renieri A, Ariani F (2013) Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases. Clin Genet. doi:10.1111/cge.12258

  • Gale DP, Oygar DD, Lin F, Oygar PD, Khan N, Connor TM, Lapsley M, Maxwell PH, Neild GH (2016) A novel COL4A1 frameshift mutation in familial kidney disease: the importance of the C-terminal NC1 domain of type IV collagen. Nephrol Dial Transplant. doi:10.1093/ndt/gfw051

  • Gomez IG, MacKenna DA, Johnson BG, Kaimal V, Roach AM, Ren S, Nakagawa N, Xin C, Newitt R, Pandya S, Xia TH, Liu X, Borza DB, Grafals M, Shankland SJ, Himmelfarb J, Portilla D, Liu S, Chau BN, Duffield JS (2015) Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways. J Clin Invest 125(1):141–156. doi:10.1172/JCI75852

    Article  PubMed  Google Scholar 

  • Gratton MA, Rao VH, Meehan DT, Askew C, Cosgrove D (2005) Matrix metalloproteinase dysregulation in the stria vascularis of mice with Alport syndrome: implications for capillary basement membrane pathology. Am J Pathol 166(5):1465–1474. doi:10.1016/S0002-9440(10)62363-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gregory MC (2005) The clinical features of thin basement membrane nephropathy. Semin Nephrol 25(3):140–145, [pii] S0270929505000082

    Article  PubMed  Google Scholar 

  • Grodecki KM, Gains MJ, Baumal R, Osmond DH, Cotter B, Valli VE, Jacobs RM (1997) Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme inhibitor. J Comp Pathol 117:209–225

    Article  CAS  PubMed  Google Scholar 

  • Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M (2002) Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counseling. Nephrol Dial Transplant 17:1218–1227

    Article  PubMed  Google Scholar 

  • Gross O, Beirowski B, Koepke ML, Kuck J, Reiner M, Addicks K, Smyth N, Schulze-Lohoff E, Weber M (2003) Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. Kidney Int 63(2):438–446

    Article  CAS  PubMed  Google Scholar 

  • Gross O, Borza DB, Anders HJ, Licht C, Weber M, Segerer S, Torra R, Gubler MC, Heidet L, Harvey S, Cosgrove D, Lees G, Kashtan C, Gregory M, Savige J, Ding J, Thorner P, Abrahamson DR, Antignac C, Tryggvason K, Hudson B, Miner JH (2009a) Stem cell therapy for Alport syndrome: the hope beyond the hype. Nephrol Dial Transplant 24(3):731–734. doi:10.1093/ndt/gfn722

    Article  CAS  PubMed  Google Scholar 

  • Gross O, Weber M, Fries JW, Muller GA (2009b) Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome. Nephrol Dial Transplant 24(5):1626–1630. doi:10.1093/ndt/gfn635

    Article  PubMed  Google Scholar 

  • Gross O, Friede T, Hilgers R, Gorlitz A, Gavenis K, Ahmed R, Durr U (2012a) Safety and efficacy of the ACE-inhibitor Ramipril in Alport syndrome: the double-blind, randomized, placebo-controlled, multicenter phase III EARLY PRO-TECT Alport trial in pediatric patients. ISRN Pediatr 2012:436046. doi:10.5402/2012/436046

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Gross O, Licht C, Anders HJ, Hoppe B, Beck B, Tonshoff B, Hocker B, Wygoda S, Ehrich JH, Pape L, Konrad M, Rascher W, Dotsch J, Muller-Wiefel DE, Hoyer P, Knebelmann B, Pirson Y, Grunfeld JP, Niaudet P, Cochat P, Heidet L, Lebbah S, Torra R, Friede T, Lange K, Muller GA, Weber M (2012b) Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int 81(5):494–501. doi:10.1038/ki.2011.407

    Article  CAS  PubMed  Google Scholar 

  • Grunfeld J-P, Noel LH, Hafez S, Droz D (1985) Renal prognosis in women with hereditary nephritis. Clin Nephrol 23:267–271

    CAS  PubMed  Google Scholar 

  • Gubler M, Levy M, Broyer M, Naizot C, Gonzales G, Perrin D, Habib R (1981) Alport’s syndrome: a report of 58 cases and a review of the literature. Am J Med 70:493–505

    Article  CAS  PubMed  Google Scholar 

  • Gunwar S, Ballester F, Noelken ME, Sado Y, Ninomiya Y, Hudson BG (1998) Glomerular basement membrane. Identification of a novel disulfide-cross-linked network of alpha3, alpha4, and alpha5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome. J Biol Chem 273(15):8767–8775

    Article  CAS  PubMed  Google Scholar 

  • Guo C, Van Damme B, Vanrenterghem Y, Devriendt K, Cassiman JJ, Marynen P (1995) Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele. J Clin Invest 95(4):1832–1837. doi:10.1172/JCI117862

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Guthrie LG (1902) “Idiopathic”, or congenital, hereditary and familial hematuria. Lancet 1:1243–1246

    Article  Google Scholar 

  • Gyoneva L, Segal Y, Dorfman KD, Barocas VH (2013) Mechanical response of wild-type and Alport murine lens capsules during osmotic swelling. Exp Eye Res 113:87–91. doi:10.1016/j.exer.2013.05.008, [pii] S0014-4835(13)00127-9

    Article  CAS  PubMed  Google Scholar 

  • Haas M (2006) Thin glomerular basement membrane nephropathy: incidence in 3471 consecutive renal biopsies examined by electron microscopy. Arch Pathol Lab Med 130(5):699–706. doi:10.1043/1543-2165(2006)130[699:TGBMNI]2.0.CO;2, [pii] OA5819

    PubMed  Google Scholar 

  • Harvey SJ, Mount R, Sado Y, Naito I, Ninomiya Y, Harrison R, Jefferson B, Jacobs R, Thorner PS (2001) The inner ear of dogs with X-linked nephritis provides clues to the pathogenesis of hearing loss in X-linked Alport syndrome. Am J Pathol 159(3):1097–1104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Heidet L, Cai Y, Sado Y, Ninomiya Y, Thorner P, Guicharnaud L, Boye E, Chauvet V, Solal LC, Beziau A, Torres RG, Antignac C, Gubler MC (1997) Diffuse leiomyomatosis associated with X-linked Alport syndrome: extracellular matrix study using immunohistochemistry and in situ hybridization. Lab Investig 76(2):233–243

    CAS  PubMed  Google Scholar 

  • Hertz JM, Thomassen M, Storey H, Flinter F (2012) Clinical utility gene card for: Alport syndrome. Eur J Hum Genet: EJHG 20(6). doi:10.1038/ejhg.2011.237

  • Hinglais N, Grunfeld J-P, Bois LE (1972) Characteristic ultrastructural lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport’s syndrome). Lab Investig 27:473–487

    CAS  PubMed  Google Scholar 

  • Hladunewich MA, Melamad N, Bramham K (2016) Pregnancy across the spectrum of chronic kidney disease. Kidney Int 89(5):995–1007. doi:10.1016/j.kint.2015.12.050

    Article  PubMed  Google Scholar 

  • Hudson BG (2004) The molecular basis of Goodpasture and Alport syndromes: beacons for the discovery of the collagen IV family. J Am Soc Nephrol 15(10):2514–2527. doi:10.1097/01.ASN.0000141462.00630.76

    Article  PubMed  Google Scholar 

  • Iijima K, Nozu K, Kamei K, Nakayama M, Ito S, Matsuoka K, Ogata T, Kaito H, Nakanishi K, Matsuo M (2010) Severe Alport syndrome in a young woman caused by a t(X;1)(q22.3;p36.32) balanced translocation. Pediatr Nephrol 25(10):2165–2170. doi:10.1007/s00467-010-1514-1

    Article  PubMed  Google Scholar 

  • Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer K-O, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2000) X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 11:649–657

    CAS  PubMed  Google Scholar 

  • Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Dahan K, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2003) X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to to 195 families: a “European Community Alport syndrome concerted action” study. J Am Soc Nephrol 14:2603–2610

    Article  PubMed  Google Scholar 

  • Jefferson JA, Lemmink HH, Hughes AE, Hill CM, Smeets HJ, Doherty CC, Maxwell AP (1997) Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4). Nephrol Dial Transplant 12(8):1595–1599

    Article  CAS  PubMed  Google Scholar 

  • Jonsson JJ, Renieri A, Gallagher PG, Kashtan CE, Cherniske EM, Bruttini M, Piccini M, Vitelli F, Ballabio A, Pober BR (1998) Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis: a new X linked contiguous gene deletion syndrome? J Med Genet 35(4):273–278

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kalluri R, van den Heuvel LP, Smeets HJM, Schroder CH, Lemmink HH, Boutaud A, Neilson EG, Hudson BG (1995) A COL4A3 gene mutation and post-transplant anti-a3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 47:1199–1204

    Article  CAS  PubMed  Google Scholar 

  • Kamiyoshi N, Nozu K, Fu XJ, Morisada N, Nozu Y, Ye MJ, Imafuku A, Miura K, Yamamura T, Minamikawa S, Shono A, Ninchoji T, Morioka I, Nakanishi K, Yoshikawa N, Kaito H, Iijima K (2016) Genetic, clinical, and pathologic backgrounds of patients with autosomal dominant Alport syndrome. Clin J Am Soc Nephrol 11(8):1441–1449. doi:10.2215/CJN.01000116

    Article  PubMed  PubMed Central  Google Scholar 

  • Kashtan CE (2002) Alport syndrome and thin basement membrane disease. Curr Diagn Pathol 8:349–360

    Article  Google Scholar 

  • Kashtan CE (2005) The nongenetic diagnosis of thin basement membrane nephropathy. Semin Nephrol 25:159–162

    Article  PubMed  Google Scholar 

  • Kashtan CE (2006) Renal transplantation in patients with Alport syndrome. Pediatr Transplant. in press

    Google Scholar 

  • Kashtan C, Fish AJ, Kleppel M, Yoshioka K, Michael AF (1986) Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis. J Clin Invest 78:1035–1044

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kashtan CE, Kleppel MM, Gubler MC (1996) Immunohistologic findings in Alport syndrome. Contrib Nephrol 117:142–153

    Article  CAS  PubMed  Google Scholar 

  • Kashtan CE, Gubler MC, Sisson-Ross S, Mauer M (1998) Chronology of renal scarring in males with Alport syndrome. Pediatr Nephrol 12(4):269–274

    Article  CAS  PubMed  Google Scholar 

  • Kashtan CE, Segal Y, Flinter F, Makanjuola D, Gan JS, Watnick T (2010) Aortic abnormalities in males with Alport syndrome. Nephrol Dial Transplant 25(11):3554–3560. doi:10.1093/ndt/gfq271

    Article  PubMed  PubMed Central  Google Scholar 

  • Kashtan CE, Ding J, Gregory M, Gross O, Heidet L, Knebelmann B, Rheault M, Licht C, Alport Syndrome Research Collaborative (2013) Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport syndrome research collaborative. Pediatr Nephrol 28(1):5–11. doi:10.1007/s00467-012-2138-4

    Article  PubMed  Google Scholar 

  • Kato T, Watanabe Y, Nakayasu K, Kanai A, Yajima Y (1998) The ultrastructure of the lens capsule abnormalities in Alport’s syndrome. Jpn J Ophthalmol 42:401–405

    Article  CAS  PubMed  Google Scholar 

  • Khoshnoodi J, Cartailler JP, Alvares K, Veis A, Hudson BG (2006) Molecular recognition in the assembly of collagens: terminal noncollagenous domains are key recognition modules in the formation of triple helical protomers. J Biol Chem 281(50):38117–38121. doi:10.1074/jbc.R600025200

    Article  CAS  PubMed  Google Scholar 

  • Khoshnoodi J, Pedchenko V, Hudson BG (2008) Mammalian collagen IV. Microsc Res Tech 71(5):357–370. doi:10.1002/jemt.20564

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim KH, Kim Y, Gubler MC, Steffes MW, Lane PH, Kashtan CE, Crosson JT, Mauer SM (1995) Structural-functional relationships in Alport syndrome. J Am Soc Nephrol 5(9):1659–1668

    CAS  PubMed  Google Scholar 

  • Kiryluk K, Novak J (2014) The genetics and immunobiology of IgA nephropathy. J Clin Invest 124(6):2325–2332. doi:10.1172/JCI74475

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kleppel MM, Santi PA, Cameron JD, Wieslander J, Michael AF (1989) Human tissue distribution of novel basement membrane collagen. Am J Pathol 134:813–825

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kovacs G, Kalmar T, Endreffy E, Ondrik Z, Ivanyi B, Rikker C, Haszon I, Turi S, Sinko M, Bereczki C, Maroti Z (2016) Efficient targeted next generation sequencing-based workflow for differential diagnosis of Alport-related disorders. PLoS One 11(3):e0149241. doi:10.1371/journal.pone.0149241

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lang S, Stevenson B, Risdon RA (1990) Thin basement membrane nephropathy as a cause of recurrent haematuria in childhood. Histopathology 16:331–337

    Article  CAS  PubMed  Google Scholar 

  • Lemmink HH, Nillesen WN, Mochizuki T, Schroder CH, Brunner HG, van Oost BA, Monnens LA, Smeets HJ (1996) Benign familial hematuria due to mutation of the type IV collagen alpha4 gene. J Clin Invest 98(5):1114–1118. doi:10.1172/JCI118893

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Levy M, Feingold J (2000) Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int 58(3):925–943. doi:10.1046/j.1523-1755.2000.00250.x

    Article  CAS  PubMed  Google Scholar 

  • Lin X, Suh JH, Go G, Miner JH (2014) Feasibility of repairing glomerular basement membrane defects in Alport syndrome. J Am Soc Nephrol 25(4):687–692. doi:10.1681/ASN.2013070798

    Article  CAS  PubMed  Google Scholar 

  • Liu YB, Tan SJ, Sun ZY, Li X, Huang BY, Hu QM (2008) Clear lens phacoemulsification with continuous curvilinear capsulorhexis and foldable intraocular lens implantation for the treatment of a patient with bilateral anterior lenticonus due to Alport syndrome. J Int Med Res 36(6):1440–1444

    Article  CAS  PubMed  Google Scholar 

  • Malone AF, Phelan PJ, Hall G, Cetincelik U, Homstad A, Alonso AS, Jiang R, Lindsey TB, Wu G, Sparks MA, Smith SR, Webb NJ, Kalra PA, Adeyemo AA, Shaw AS, Conlon PJ, Jennette JC, Howell DN, Winn MP, Gbadegesin RA (2014) Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. Kidney Int 86(6):1253–1259. doi:10.1038/ki.2014.305

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Marcocci E, Uliana V, Bruttini M, Artuso R, Silengo MC, Zerial M, Bergesio F, Amoroso A, Savoldi S, Pennesi M, Giachino D, Rombola G, Fogazzi GB, Rosatelli C, Martinhago CD, Carmellini M, Mancini R, Di Costanzo G, Longo I, Renieri A, Mari F (2009) Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome. Nephrol Dial Transplant 24(5):1464–1471. doi:10.1093/ndt/gfn681

    Article  CAS  PubMed  Google Scholar 

  • Marks MI, Drummond KN (1969) Benign familial hematuria. Pediatrics 44:590–593

    CAS  PubMed  Google Scholar 

  • Martin P, Heiskari N, Zhou J, Leinonen A, Tumelius T, Hertz JM, Barker D, Gregory M, Atkin C, Sturkarsdottir U, Neumann H, Springate J, Shows T, Pettersson E, Tryggvason K (1998) High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing. J Am Soc Nephrol 9:2291–2301

    CAS  PubMed  Google Scholar 

  • Massella L, Muda AO, Legato A, Di Zazzo G, Giannakakis K, Emma F (2010) Cyclosporine A treatment in patients with Alport syndrome: a single-center experience. Pediatr Nephrol 25(7):1269–1275. doi:10.1007/s00467-010-1484-3

    Article  PubMed  Google Scholar 

  • McConville JM, West CD, McAdams AJ (1966) Familial and nonfamilial benign hematuria. J Pediatr 69:207–214

    Article  CAS  PubMed  Google Scholar 

  • Meehan DT, Delimont D, Cheung L, Zallocchi M, Sansom SC, Holzclaw JD, Rao V, Cosgrove D (2009) Biomechanical strain causes maladaptive gene regulation, contributing to Alport glomerular disease. Kidney Int 76(9):968–976. doi:10.1038/ki.2009.324

    Article  PubMed  PubMed Central  Google Scholar 

  • Mencarelli MA, Heidet L, Storey H, van Geel M, Knebelmann B, Fallerini C, Miglietti N, Antonucci MF, Cetta F, Sayer JA, van den Wijngaard A, Yau S, Mari F, Bruttini M, Ariani F, Dahan K, Smeets B, Antignac C, Flinter F, Renieri A (2015) Evidence of digenic inheritance in Alport syndrome. J Med Genet 52(3):163–174. doi:10.1136/jmedgenet-2014-102822

    Article  CAS  PubMed  Google Scholar 

  • Merchant SN, Burgess BJ, Adams JC, Kashtan CE, Gregory MC, Santi PA, Colvin R, Collins B, Nadol JB Jr (2004) Temporal bone histopathology in alport syndrome. Laryngoscope 114(9):1609–1618

    Article  PubMed  Google Scholar 

  • Milanesi C, Rizzoni G, Braggion F, Galdiolo D (1984) Electron microscopy for measurement of glomerular basement membrane width in children with benign familial hematuria. Appl Pathol 2:199–204

    CAS  PubMed  Google Scholar 

  • Miner JH (2012) The glomerular basement membrane. Exp Cell Res 318(9):973–978. doi:10.1016/j.yexcr.2012.02.031

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miner JH (2014) Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome. Kidney Int 86(6):1081–1083. doi:10.1038/ki.2014.326

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schroder CH, Smeets HJ et al (1994) Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8(1):77–81. doi:10.1038/ng0994-77

    Article  CAS  PubMed  Google Scholar 

  • Moriniere V, Dahan K, Hilbert P, Lison M, Lebbah S, Topa A, Bole-Feysot C, Pruvost S, Nitschke P, Plaisier E, Knebelmann B, Macher MA, Noel LH, Gubler MC, Antignac C, Heidet L (2014) Improving mutation screening in familial Hematuric nephropathies through next generation sequencing. J Am Soc Nephrol. doi:10.1681/ASN.2013080912

  • Nabais Sa MJ, Storey H, Flinter F, Nagel M, Sampaio S, Castro R, Araujo JA, Gaspar MA, Soares C, Oliveira A, Henriques AC, da Costa AG, Abreu CP, Ponce P, Alves R, Pinho L, Silva SE, de Moura CP, Mendonca L, Carvalho F, Pestana M, Alves S, Carvalho F, Oliveira JP (2015) Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families. Clin Genet 88(5):456–461. doi:10.1111/cge.12521

    Article  CAS  PubMed  Google Scholar 

  • Nieuwhof CM, de Heer F, de Leeuw P, van Breda Vriesman PJ (1997) Thin GBM nephropathy: premature glomerular obsolescence is associated with hypertension and late onset renal failure. Kidney Int 51:1596–1601

    Article  CAS  PubMed  Google Scholar 

  • Ninichuk V, Gross O, Reichel C, Kandoga A, Pawar RD, Ciubar R, Segerer S, Belemezova E, Radomska E, Lcukow B, Perez de Lema G, Murphy PM, Gao J, Henger A, Kretzler M, Horuk R, Weber M, Krombach F, Schlondorff D, Anders H (2005) Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient miche with Alport disease. J Am Soc Nephrol 16:977–985

    Article  CAS  PubMed  Google Scholar 

  • Ohkubo S, Takeda H, Higashide T, Ito M, Sakurai M, Shirao Y, Yanagida T, Oda Y, Sado Y (2003) Immunohistochemical and molecular genetic evidence for type IV collagen alpha5 chain abnormality in the anterior lenticonus associated with Alport syndrome. Arch Ophthalmol 121(6):846–850. doi:10.1001/archopht.121.6.846

    Article  CAS  PubMed  Google Scholar 

  • Oka M, Nozu K, Kaito H, Fu XJ, Nakanishi K, Hashimura Y, Morisada N, Yan K, Matsuo M, Yoshikawa N, Vorechovsky I, Iijima K (2014) Natural history of genetically proven autosomal recessive Alport syndrome. Pediatr Nephrol 29(9):1535–1544. doi:10.1007/s00467-014-2797-4

    Article  PubMed  Google Scholar 

  • Olson DL, Anand SK, Landing BH, Heuser E, Grushkin CM, Lieberman E (1980) Diagnosis of hereditary nephritis by failure of glomeruli to bind anti-glomerular basement membrane antibodies. J Pediatr 96:697–699

    Article  CAS  PubMed  Google Scholar 

  • Peissel B, Geng L, Kalluri R, Kashtan C, Rennke HG, Gallo GR, Yoshioka K, Sun MJ, Hudson BG, Neilson EG, Zhou J (1995) Comparative distribution of the a1(IV), a5(IV) and a6(IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patients. J Clin Invest 96:1948–1957

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Petrova DT, Schultze FC, Brandhorst G, Luchs KD, Lenz C, Urlaub H, Rubel D, Gross O, Walson PD, Oellerich M (2014) Effects of mycophenolate mofetil on kidney function and phosphorylation status of renal proteins in Alport COL4A3-deficient mice. Proteome Sci 12(1):56. doi:10.1186/s12953-014-0056-z

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Pettersson E, Tornroth T, Wieslander J (1990) Abnormally thin glomerular basement membrane and the Goodpasture epitope. Clin Nephrol 33:105–109

    CAS  PubMed  Google Scholar 

  • Piqueras AI, White RH, Raafat F, Moghal N, Milford DV (1998) Renal biopsy diagnosis in children presenting with haematuria. Pediatr Nephrol 12(5):386–391

    Article  CAS  PubMed  Google Scholar 

  • Plaisier E, Gribouval O, Alamowitch S, Mougenot B, Prost C, Verpont MC, Marro B, Desmettre T, Cohen SY, Roullet E, Dracon M, Fardeau M, Van Agtmael T, Kerjaschki D, Antignac C, Ronco P (2007) COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Engl J Med 357(26):2687–2695. doi:10.1056/NEJMoa071906

    Article  CAS  PubMed  Google Scholar 

  • Plaisier E, Chen Z, Gekeler F, Benhassine S, Dahan K, Marro B, Alamowitch S, Paques M, Ronco P (2010) Novel COL4A1 mutations associated with HANAC syndrome: a role for the triple helical CB3[IV] domain. Am J Med Genet A 152A(10):2550–2555. doi:10.1002/ajmg.a.33659

    Article  CAS  PubMed  Google Scholar 

  • Poschl E, Pollner R, Kuhn K (1988) The genes for the alpha 1(IV) and alpha 2(IV) chains of human basement membrane collagen type IV are arranged head-to-head and separated by a bidirectional promoter of unique structure. EMBO J 7(9):2687–2695

    CAS  PubMed  PubMed Central  Google Scholar 

  • Proesmans W, Van Dyck M (2004) Enalapril in children with Alport syndrome. Pediatr Nephrol 19(3):271–275

    Article  PubMed  Google Scholar 

  • Rana K, Wang YY, Buzza M, Tonna S, Zhang KW, Lin T, Sin L, Padavarat S, Savige J (2005) The genetics of thin basement membrane nephropathy. Semin Nephrol 25:163–170

    Article  CAS  PubMed  Google Scholar 

  • Redahan L, Doyle R, O'Shaughnessy M, Dorman A, Little M, Conlon P (2014) Familial MPGN – a case series: a clinical description of familial membranoproliferative glomerulonephritis amongst three Irish families. Ren Fail:1–4. doi:10.3109/0886022X.2014.931681

  • Rheault MN (2012) Women and Alport syndrome. Pediatr Nephrol 27(1):41–46. doi:10.1007/s00467-011-1836-7

    Article  PubMed  Google Scholar 

  • Rheault MN, Kren SM, Hartich LA, Wall M, Thomas W, Mesa HA, Avner P, Lees GE, Kashtan CE, Segal Y (2010) X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome. Nephrol Dial Transplant 25(3):764–769. doi:10.1093/ndt/gfp551

    Article  CAS  PubMed  Google Scholar 

  • Rhys C, Snyers B, Pirson Y (1997) Recurrent corneal erosion associated with Alport’s syndrome. Kidney Int 52:208–211

    Article  CAS  PubMed  Google Scholar 

  • Rubel D, Stock J, Ciner A, Hiller H, Girgert R, Muller GA, Gross O (2014) Antifibrotic, nephroprotective effects of paricalcitol versus calcitriol on top of ACE-inhibitor therapy in the COL4A3 knockout mouse model for progressive renal fibrosis. Nephrol Dial Transplant 29(5):1012–1019. doi:10.1093/ndt/gft434

    Article  CAS  PubMed  Google Scholar 

  • Rumpelt HJ (1980) Hereditary nephropathy (Alport syndrome): correlation of clinical data with glomerular basement membrane alterations. Clin Nephrol 13(5):203–207

    CAS  PubMed  Google Scholar 

  • Sa MJ, Fieremans N, de Brouwer AP, Sousa R, e Costa FT, Brito MJ, Carvalho F, Rodrigues M, de Sousa FT, Felgueiras J, Neves F, Carvalho A, Ramos U, Vizcaino JR, Alves S, Carvalho F, Froyen G, Oliveira JP (2013) Deletion of the 5′ exons of COL4A6 is not needed for the development of diffuse leiomyomatosis in patients with Alport syndrome. J Med Genet 50(11):745–753. doi:10.1136/jmedgenet-2013-101670

    Article  CAS  PubMed  Google Scholar 

  • Saran R, Li Y, Robinson B, Abbott KC, Agodoa LY, Ayanian J, Bragg-Gresham J, Balkrishnan R, Chen JL, Cope E, Eggers PW, Gillen D, Gipson D, Hailpern SM, Hall YN, He K, Herman W, Heung M, Hirth RA, Hutton D, Jacobsen SJ, Kalantar-Zadeh K, Kovesdy CP, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, Nguyen DV, O'Hare AM, Plattner B, Pisoni R, Port FK, Rao P, Rhee CM, Sakhuja A, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, White S, Woodside K, Hirth RA (2016) US renal data system 2015 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis: Off J Natl Kidney Found 67(3 Suppl 1):Svii, S1–Svii,305. doi:10.1053/j.ajkd.2015.12.014

    Google Scholar 

  • Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY (2003) Thin basement membrane nephropathy. Kidney Int 64(4):1169–1178. doi:10.1046/j.1523-1755.2003.00234.x

    Article  PubMed  Google Scholar 

  • Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F (2013) Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol 24(3):364–375. doi:10.1681/ASN.2012020148

    Article  CAS  PubMed  Google Scholar 

  • Savige J, Sheth S, Leys A, Nicholson A, Mack HG, Colville D (2015) Ocular features in Alport syndrome: pathogenesis and clinical significance. Clin J Am Soc Nephrol 10(4):703–709. doi:10.2215/CJN.10581014

    Article  PubMed  PubMed Central  Google Scholar 

  • Savige J, Colville D, Rheault M, Gear S, Lennon R, Lagas S, Finlay M, Flinter F (2016) Alport syndrome in women and girls. Clin J Am Soc Nephrol. doi:10.2215/CJN.00580116

  • Sayers R, Kalluri R, Rodgers KD, Shield CF, Meehan DT, Cosgrove D (1999) Role for transforming growth factor-beta 1 in Alport renal disease progression. Kidney Int 56:1662–1673

    Article  CAS  PubMed  Google Scholar 

  • Schroder CH, Bontemps CM, Assmann KJ, Schuurmans Stekhoven JH, Foidart JM, Monnens LA, Veerkamp JH (1990) Renal biopsy and family studies in 65 children with isolated hematuria. Acta Paediatr Scand 79(6–7):630–636

    Article  CAS  PubMed  Google Scholar 

  • Segal Y, Zhuang L, Rondeau E, Sraer JD, Zhou J (2001) Regulation of the paired type IV collagen genes COL4A5 and COL4A6. Role of the proximal promoter region. J Biol Chem 276(15):11791–11797. doi:10.1074/jbc.M007477200

    Article  CAS  PubMed  Google Scholar 

  • Sonarkhan S, Ramappa M, Chaurasia S, Mulay K (2014) Bilateral anterior lenticonus in a case of Alport syndrome: a clinical and histopathological correlation after successful clear lens extraction. BMJ Case Rep. doi:10.1136/bcr-2013-202036

  • Stefanou C, Pieri M, Savva I, Georgiou G, Pierides A, Voskarides K, Deltas C (2015) Co-inheritance of functional Podocin variants with heterozygous collagen IV mutations predisposes to renal failure. Nephron 130(3):200–212. doi:10.1159/000432406

    Article  CAS  PubMed  Google Scholar 

  • Steffes MW, Barbosa J, Basgen JM, Sutherland DER, Najarian JS, Mauer SM (1983) Quantitative glomerular morphology of the normal human kidney. Kidney Int 49:82–86

    CAS  Google Scholar 

  • Storey H, Savige J, Sivakumar V, Abbs S, Flinter FA (2013) COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. J Am Soc Nephrol. doi:10.1681/ASN.2012100985

  • Sugimoto H, Mundel TM, Sund M, Xie L, Cosgrove D, Kalluri R (2006) Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci U S A 103(19):7321–7326

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sugimoto K, Fujita S, Miyazawa T, Nishi H, Enya T, Izu A, Wada N, Sakata N, Okada M, Takemura T (2014) Cyclosporin A may cause injury to undifferentiated glomeruli persisting in patients with Alport syndrome. Clin Exp Nephrol 18(3):492–498. doi:10.1007/s10157-013-0836-2

    Article  CAS  PubMed  Google Scholar 

  • Teekhasaenee C, Nimmanit S, Wutthiphan S, Vareesangthip K, Laohapand T, Malasitr P, Ritch R (1991) Posterior polymorphous dystrophy and Alport syndrome. Ophthalmology 98:1207–1215

    Article  CAS  PubMed  Google Scholar 

  • Temme J, Kramer A, Jager KJ, Lange K, Peters F, Muller GA, Kramar R, Heaf JG, Finne P, Palsson R, Reisaeter AV, Hoitsma AJ, Metcalfe W, Postorino M, Zurriaga O, Santos JP, Ravani P, Jarraya F, Verrina E, Dekker FW, Gross O (2012a) Outcomes of male patients with Alport syndrome undergoing renal replacement therapy. Clin J Am Soc Nephrol 7(12):1969–1976. doi:10.2215/CJN.02190312

    Article  PubMed  PubMed Central  Google Scholar 

  • Temme J, Peters F, Lange K, Pirson Y, Heidet L, Torra R, Grunfeld JP, Weber M, Licht C, Muller GA, Gross O (2012b) Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations. Kidney Int 81(8):779–783. doi:10.1038/ki.2011.452

    Article  CAS  PubMed  Google Scholar 

  • Tiebosch ATMG, Frederik PM, van Breda Vriesman PJC, Mooy JMV, van Rie H, van de Wiel TWM, Wolters J, Zeppenfeldt E (1989) Thin-basement-membrane nephropathy in adults with persistent hematuria. N Engl J Med 320:14–18

    Article  CAS  PubMed  Google Scholar 

  • Trachtman H, Weiss RA, Bennett B, Greifer I (1984) Isolated hematuria in children: indications for a renal biopsy. Kidney Int 25(1):94–99

    Article  CAS  PubMed  Google Scholar 

  • Tryggvason K, Patrakka J (2006) Thin basement membrane nephropathy. J Am Soc Nephrol 17(3):813–822. doi:10.1681/ASN.2005070737

    Article  CAS  PubMed  Google Scholar 

  • van Paassen P, van Breda Vriesman PJ, van Rie H, Tervaert JW (2004) Signs and symptoms of thin basement membrane nephropathy: a prospective regional study on primary glomerular disease-the Limburg renal registry. Kidney Int 66(3):909–913. doi:10.1111/j.1523-1755.2004.00835.x, [pii] KID835

    Article  PubMed  Google Scholar 

  • Vitelli F, Piccini M, Caroli F, Franco B, Malandrini A, Pober B, Jonsson J, Sorrentino V, Renieri A (1999) Identification and characterization of a highly conserved protein absent in the Alport syndrome (A), mental retardation (M), midface hypoplasia (M), and elliptocytosis (E) contiguous gene deletion syndrome (AMME). Genomics 55(3):335–340. doi:10.1006/geno.1998.5666

    Article  CAS  PubMed  Google Scholar 

  • Vogler C, McAdams AJ, Homan SM (1987) Glomerular basement membrane and lamina densa in infants and children: an ultrastructural evaluation. Pediatr Pathol 7:527–534

    Article  CAS  PubMed  Google Scholar 

  • Wang Y, Sivakumar V, Mohammad M, Colville D, Storey H, Flinter F, Dagher H, Savige J (2014) Clinical and genetic features in autosomal recessive and X-linked Alport syndrome. Pediatr Nephrol 29(3):391–396. doi:10.1007/s00467-013-2643-0

    Article  PubMed  Google Scholar 

  • Webb NJ, Lam C, Shahinfar S, Strehlau J, Wells TG, Gleim GW, Le Bailly De Tilleghem C (2011) Efficacy and safety of losartan in children with Alport syndrome – results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trial. Nephrol Dial Transplant 26(8):2521–2526. doi:10.1093/ndt/gfq797

    Article  CAS  PubMed  Google Scholar 

  • Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C (2013) Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome. Pediatr Nephrol 28(5):737–743. doi:10.1007/s00467-012-2372-9

    Article  PubMed  Google Scholar 

  • Wester DC, Atkin CL, Gregory MC (1995) Alport syndrome: clinical update. J Am Acad Audiol 6:73–79

    CAS  PubMed  Google Scholar 

  • Yefet E, Tovbin D, Nachum Z (2016) Pregnancy outcomes in patients with Alport syndrome. Arch Gynecol Obstet 293(4):739–747. doi:10.1007/s00404-015-3893-9

    Article  CAS  PubMed  Google Scholar 

  • Yilmaz VT, Dinckan A, Yilmaz F, Suleymanlar G, Kocak H (2015) Outcomes of renal transplantation in patients with Alport syndrome. Transplant Proc 47(5):1377–1381. doi:10.1016/j.transproceed.2015.04.025

    Article  CAS  PubMed  Google Scholar 

  • Yoshioka K, Hino S, Takemura T, Maki S, Wieslander J, Takekoshi Y, Makino H, Kagawa M, Sado Y, Kashtan CE (1994) Type IV collagen a5 chain: normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol 144:986–996

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zehnder AF, Adams JC, Santi PA, Kristiansen AG, Wacharasindhu C, Mann S, Kalluri R, Gregory MC, Kashtan CE, Merchant SN (2005) Distribution of type IV collagen in the cochlea in Alport syndrome. Arch Otolaryngol Head Neck Surg 131:1007–1013

    Article  PubMed  Google Scholar 

  • Zeisberg M, Bottiglio C, Kumar N, Maeshima Y, Strutz F, Muller GA, Kalluri R (2003) Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 285(6):F1060–F1067

    Article  CAS  PubMed  Google Scholar 

  • Zeisberg M, Khurana M, Rao VH, Cosgrove D, Rougier JP, Werner MC, Shield CF 3rd, Werb Z, Kalluri R (2006) Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease. PLoS Med 3(4):e100. doi:10.1371/journal.pmed.0030100, [pii] 05-PLME-RA-0183R3

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Zenker M, Aigner T, Wendler O, Tralau T, Muntefering H, Fenski R, Pitz S, Schumacher V, Royer-Pokora B, Wuhl E, Cochat P, Bouvier R, Kraus C, Mark K, Madlon H, Dotsch J, Rascher W, Maruniak-Chudek I, Lennert T, Neumann LM, Reis A (2004) Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet 13(21):2625–2632. doi:10.1093/hmg/ddh284

    Article  CAS  PubMed  Google Scholar 

  • Zhang Y, Wang F, Ding J, Zhang H, Liu X, Wang S, Xiao H, Yao Y, Liu J, Zhong X, Guan N, Su B, Wu G, Yu L (2016) Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome. Pediatr Nephrol 31(1):67–72. doi:10.1007/s00467-015-3184-5

    Article  PubMed  Google Scholar 

  • Zhou J, Mochizuki T, Smeets H, Antignac C, Laurila P, de Paepe A, Tryggvason K, Reeders ST (1993) Deletion of the paired a5(IV) and a6(IV) collagen genes in inherited smooth muscle tumors. Science 261:1167–1169

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Nephrology, University of Minnesota Masonic Children’s Hospital, Minneapolis, MN, USA

    Michelle N. Rheault

Authors
  1. Michelle N. Rheault
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michelle N. Rheault .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, NYU Langone Medical Center, New York, New York, USA

    Howard Trachtman

  2. Hospital of the Univ. of Pennsylvania, Philadelphia, Pennsylvania, USA

    Jonathan J. Hogan

  3. Cleveland Clinic, Cleveland, Ohio, USA

    Leal Herlitz

  4. Nephrology, University of Illinois at Chicago College of Medicine, Chicago, Illinois, USA

    Edgar V. Lerma

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Rheault, M.N. (2017). Alport Syndrome and Other Collagen Disorders. In: Trachtman, H., Hogan, J., Herlitz, L., Lerma, E. (eds) Glomerulonephritis. Springer, Cham. https://doi.org/10.1007/978-3-319-27334-1_11-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27334-1_11-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27334-1

  • Online ISBN: 978-3-319-27334-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation